About ADAC Research, PA

Allergic Disease and Asthma Center (ADAC) Research, PA is an independent outpatient research facility located in Greenville, South Carolina. ADAC Research, PA has conducted phase II, III, and IV clinical trials since 1986 in a variety of therapeutic areas. We have completed over ninety studies for approximately twenty different pharmaceutical companies and clinical research organizations.

Meet our Research team below!

Investigators

Illustration

Neil Kao, MDPrinciple Investigator

Illustration

Emmanuel Sarmiento, MD
Investigator

Illustration

Candace Cothran, PA-C
Investigator

Illustration

Leigh T. Paxton PA-C
Investigator

Study Coordinators

Illustration

Rebecca FairclothHead Clinical Research Coordinator

Illustration

Elissa PeeryClinical Research Coordinator

Current Research Studies

To learn more about each of the below studies, follow the links to ClinicalTrials.gov or contact our Research Staff (864-627-3800 x221 or moc.liamg%40aphcraesercada).

KALOS Asthma Study

KALOS Asthma Study

A study on the effectiveness and safety of budesonide/glycopyrronium/formoterol inhaler in adults and adolescents with severe asthma that is inadequately controlled by standard of care.

AROMA Nasal Polyps Study

AROMA Nasal Polyps Study

A study assessing long-term outcomes of dupilumab (Dupixent®) treatment in adult patients with chronic rhinosinusitis (inflammation of the sinuses and nasal passages) with nasal polyposis.

EUTREMA Chronic Cough Study

EUTREMA Chronic Cough Study

A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamic Effects Of GDC-6599 In Patients With Chronic Cough.

PASSAGE Asthma Study

PASSAGE Asthma Study

Effectiveness and Safety Study of Tezepelumab in Adults & Adolescent Participants With Severe Asthma in the United States.

CHRONICLE Asthma Study

CHRONICLE Asthma Study

An observational study on the treatment patterns of adults with severe asthma.

ATLAS Asthma Study

ATLAS Asthma Study

A study assessing the long-term effect of dupilumab on prevention of lung function decline in adult patients with uncontrolled moderate to severe asthma.

PEDISTAD Atopic Dermatitis Studies (Enrollment Closed)

An observational study in pediatric patients with moderate to severe atopic dermatitis that is not adequately controlled with topical prescription therapies or therapies that are medically advisable.
LEARN MORE HERE (NCT03687359) >
A study evaluating biomarkers of atopic dermatitis in pediatric patients whose disease is not adequately controlled with topical prescription therapies or therapies that are medically advisable. 
LEARN MORE HERE (NCT03849716) >

Asthma Studies

Atlas - Interventional.Chronicle - Observational.Kalos - Interventional.Passage - Interventional.

Atopic Dermatitis Studies

Pedistad - Observational (Closed enrollment).

Chronic Cough Studies

Eutrema - Interventional.

Nasal Polyps

Aroma - Observational.

Research FAQ

  • WHAT IS A CLINICAL TRIAL?

    Clinical trials are conducted in a healthcare setting (hospital or clinic) and are monitored by a trained healthcare professional. An Institutional Review Board (IRB) is a committee made up of doctors, ethicists, members of the general public, and administrators that approves andmonitors all clinical trials. This group is held responsible for agreeing that a trial does not represent an unreasonable risk to patients who are participating. Trials are also reviewed by the U.S. Food and Drug Administration (FDA). Your doctor is responsible for your well-being and is the best person to decide whether or not a clinical trial is right for you.

  • WHAT ARE THE BENEFITS OF PARTICIPATING IN A CLINCAL TRIAL?

    In many cases, research studies give participants opportunities to access medications that are not yet available over-the-counter or with a prescription.
    Often times, the information collected during a study can allow your doctor to learn more about your specific disease state and how it affects you. This may help your doctor provide you with better care during and after your study participation.

    There are some cases where clinical trial participants are not treated with new medications, such as during an observational trial. However, many patients who participate in these trials derive satisfaction from knowing they play a role in the effort to reduce the sufferingof other people.

  • ARE THERE ANY RISKS INVOLVED WITH PARTICIPATING IN A CLINICAL TRIAL?

    Medication Safety: Clinical trials are conducted in phases to determine the safety and effectiveness of a product in careful steps to help minimizethe risks presented to participants. To learn more about the different phases of clinical trials, go to https://www.nih.gov/health-information/nih-clinical-research-trials-you/basics#6.
    For more information about the safety of the investigational products tested at ADAC Research, PA, speak with one of our Investigators or Clinical Research Coordinators.
    Data Privacy: If you participate in a clinical trial, all of your data will be stored using a unique subject identification (ID) number. Only our research staff at ADAC Research, PA and our site monitors can affiliate your subject ID number with your personal information. A site monitor is a representative working for the study sponsor who can review your study data while physically on-site at our Butler Road office, but who cannot leave our site with any of your personal identifying information.
    Time Commitment: Research study visits are often longer and scheduled more frequently than routine doctors’ visits, so they can require more timecommitment. However, all assessments completed during these visits are performed at no monetary cost to you and can help the study doctor understand your specific symptoms which may help them provide you with better care.

  • HOW WILL I KNOW IF I AM ELIGIBLE FOR A CLINICAL TRIAL?

    Talk to your doctor and/or our research department to find out if a trial is right for you.

  • WHAT WILL PARTICIPATING IN A CLINICAL TRIAL REQUIRE OF ME?

    A patient’s involvement in a clinical trial will vary based on the study. For this reason, every clinical trial is required to provide patients with an informed consent form they must sign prior to study participation. An informed consent form explains a patient’s role in a research study and outlines exactly what is expected of the patient during their participation in the trial. It also explains the potential sideeffects of the medication being tested (if applicable), potential risks and benefits of the specific study, whether or not the patient is compensated for their participation, and more.

CONTACT US

If you have any questions, feel free to contact us using the information below or fill out the contact form.

Address

1202 E Butler Rd, Greenville, SC 29607

Contacts

P. (864) 627-3800, Ext 221 or 223F. (864) 672-2654, Attn: Researchmoc.esaesidcigrella%40hcraeser